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Dear Past, Present, and Future BMS Family,
A year after we published the inaugural issue of our Biomedical Science Magazine, “We Are…
Bridging Medicine and Science,” our program has continued to strive for research excellence
within its five research clusters.
Big and exciting changes have happened in just one year’s time here at Marshall, starting with the
opening and dedication of the McKown Translational Genomic Research Institute, which is housed
inside the Edwards Comprehensive Cancer Center at Cabell Huntington Hospital. The opening of
this facility has sparked several new and exciting clinical trials, which indicates a new and dynamic
working environment with clinicians. The collaborative effort between BMS faculty and clinicians
at Cabell Huntington Hospital is now expanding at an even faster pace after the appointment of
the new Joan C. Edwards School of Medicine dean, Dr. Joseph Shapiro.
As always, the graduate students are at the heart of our thriving research program. In the past
year, the students have attended several local and national conferences educating others about
the research endeavors at Marshall. We have also worked alongside our Principal Investigators
to provide multi-disciplinary research training to undergraduate students, through both the WVINBRE and SRIMS undergraduate internship programs. Furthermore, our BMS Medical Sciences
students have continued to find great success in being accepted to and succeeding in medical
school. Additionally, our Graduate Student Organization has been very active, and has completed
several philanthropic endeavors, as well as partnering with several outreach programs to continue
to advocate for the importance of funding biomedical research.

M. Allison Wolf

In conclusion, faculty and students across all research disciplines at Marshall continue to
collaborate to make this program strong and vibrant. The future continues to look bright as we
start the year with 23 new incoming students.
We hope you enjoy the second annual “We Are…Bridging Medicine and Science” publication! And
of course… Go Herd!
Sincerely,

M. Allison Wolf

M. Allison Wolf
Ph.D. Candidate
Graduate Student Organization President
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Peppers and Potential: Dr. Piyali Dasgupta’s
Inroads into Lung Cancer Research
by Lisa Shrewsberry

There is a saying around the campfire that “smoke follows beauty.” Science bears
witness to the anecdote, only in reverse, as the beauty of Dr. Piyali Dasgupta’s research
has consistently, effectively pursued smoke. Her contributions to the enlarging body of
evidence about nicotine, the addictive component of cigarettes, continues making vital
inroads into lung cancer research. As Associate Professor and part of the Nutrition and
Cancer Center at Marshall University, she is in the mix of scientists exploring the intricacies
of cancer and its causes, to the end of seeking potential cures and treatments.
From New Delhi, India, Dasgupta arrived
in the U.S. in 2000 for a post-doctoral
fellowship at Columbia University in New
York. When her mentor relocated to the
Moffitt Cancer Center in Tampa, Florida,
she moved to join him. Upon completion
of her fellowship, the Ph.D.-level researcher
initially arrived at Marshall University to
become a tenure-track Assistant Professor.
Her lab is an arena where battle happens
at the cellular level, exposing mechanisms
by which the dangerous components
of cigarette smoke, such as nicotine and
nicotine-derived nitrosamine ketone (NNK),
facilitate the survival and accelerate the
progression of lung cancers. She fights a
formidable foe: Lung cancer is one of the
deadliest malignancies facing both men
and women, a fact prompting the insatiable
scholar to explore, explore, explore.

Disease Control and Prevention data, WV
ranks highest for tobacco usage among
adults in America.
“Research work in our lab is very relevant
to the health of local people,” Dasgupta
emphasized.
Searching nature’s storehouse for potential
cancer therapies, her most interesting
work surrounds capsaicin, a component of
common chili peppers. She is measuring the
compound’s ability to slow the progression
of lung cancer cells.
“The Nutrition and Cancer Center is
relatively new at Marshall University.
There has been evidence that capsaicin
suppresses the growth of several human
cancers, including prostate and breast
cancer,” Dasgupta explained.

“What I’ve done so far is to try and
understand how nicotine promotes lung
cancer and protects lung tumors against
anti-cancer drugs,” Dasgupta said. “By
coincidence, I’m in West Virginia, where the
tobacco consumption rates are very high.”

Within her career, her most exciting
involvement has been discovering that
exposure to nicotine can decrease a
patient’s response to chemotherapy. It is
part and parcel to the relentless syndrome
of smoking.

While not a tobacco producer itself,
sandwiched between Pennsylvania and
prolific producer North Carolina, the state
is certainly a substantial tobacco consumer.
According to most current Centers for

“Nicotine itself is not a cancer-causing
compound. Other carcinogens initiate
the cancer,” Dasgupta remarked. “But after
initiation, consistent exposure to nicotine
can actually help cancer grow.”
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The finding opened up a significant
debate, which in the realm of research
spawns discovery. Would cancer patients
exposed to nicotine replacement
therapies demonstrate a lesser response to
chemotherapy? If a non-smoking cancer
patient were in contact with someone else’s
smoke, would it affect their treatment?
The answers aren’t yet clear. “This is just the
beginning,” she said, “but I am hoping as we
get more data we will be able to collaborate
with some clinicians and take the findings
to the next therapeutic level.”
Outside her lab, Dasgupta is an advocate
for clean air and smoke-free environments
within Cabell County’s Coalition for Clean
Air. Part of the group’s purpose is to raise
awareness about the effects of smoking
inside homes and cars. As part of the
Tobacco Prevention Committee at Marshall
University, one of her ambitions is to see
Marshall University through to becoming
a smoke-free campus. Another of her
goals is to raise awareness of the hazard of
third-hand smoke, examining the harmful
compounds from cigarette smoke and their
absorption by materials that transfer healthadverse substances to others.
“If someone is smoking in a car, it gets
absorbed by everything inside — the seats,
the dashboard. (Third-hand smoke transfer)
may not be bad for adults, but for children
with a higher respiratory rate, it can harm
them,” Dasgupta explained.
Yet a third emerging arm of Dasgupta’s
research is investigating the gender basis
of lung cancer. “Women are more prone to
lung cancer than men, whether they smoke
or not.”

“What I’ve done so far is to try and
understand how nicotine promotes lung
cancer and protects lung tumors against
anti-cancer drugs,” Dasgupta said. “By
coincidence, I’m in West Virginia, where the
tobacco consumption rates are very high.”

continued on page 6
BIO M BE IDOI M
C AELD ISCCAI EL NSCCEI SE NGCREASDGUAT
R A DE UAT
P R OEGPRRAM
O G R AM
5

5

F E A T U R E

F E A T U R E

S T O R Y

S T O R Y

We Are...A Better Advantage
through Medical Sciences
by Lisa Shrewsberry

Peppers and Potential, continued from page 4
The anomaly intrigues Dasgupta, as it does
many of her research students, eager to get
at a scientifically sound answer.
Dasgupta is seeking publication of her
findings in both science and medical
journals in order to transfer the findings
from research to patient therapies. Her
constant search for funding to perpetuate
research has brought support from
many groups, including FAMRI, the Flight
Attendant Medical Research Institute,
formed from a class action lawsuit brought
by non-smoking flight attendants against
the tobacco industry. The non-profit

6
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medical and scientific research organization
formed as part of the settlement for
the diseases and deaths attributable to
second-hand smoke within airline cabins.
Recently, she was awarded a National
Institutes of Health grant to support her
studies involving capsaicin and lung
cancer therapy. Others who have funded
Dasgupta’s research include NASA, the
American Retina Foundation and the
American Society for Pharmacology and
Experimental Therapeutics.
“With the economy being what it is, I try
to approach funding at every level — for
master’s level students, fellowships and
summer students for stipends,” Dasgupta

explained. “Many of my students aim to
be physician-scientists and to do scientific
research throughout their career.”
To those outside her lab who go about
their daily lives unaware of her quiet
explorations, a chili pepper is a chili pepper.
But to Dasgupta and her students, driven
to seek scientific solutions to our health
problems, these peppers are potential.
“If you ask most medical school candidates,
they aren’t aware of the possibilities
research offers,” Dasgupta said. “That is
something that excites me immensely. It
is part of my job to motivate students into
research.”

The Marshall Medical Sciences
program is for students
determined to make it in medicine
— whether uncertain about their
proficiency, delayed in acceptance
to medical school or making up
for lost academic time. A preview
with a purpose, the classes taken
alongside MUSOM medical
students also serve as a testing
ground for preparedness for
medicine as a fulfilling career.
There are few linear pathways toward the
title “Dr.” Promising physicians exist in all
manner of circumstances — including
those who desire to practice medicine from
childhood, realizing the tug is more than
whim; those who feel the calling to switch
to medicine from an unfulfilling career;
and those who have the will, but lack the
competitive edge necessary for getting
noticed from a crowded candidate pool.
As students seeking admission to medical
school must become more and do more
to get noticed, the need for proactive
advantage arises.

Brittany Wall had
a rude awakening.
A graduating
senior from
Auburn University,
she questioned
her readiness
for the most
important step
toward becoming
a physician —
medical school.
Originally from Ashland, Kentucky, the
24-year-old quashed any cause to celebrate.
“I began submitting applications and it was
a horrible process. I called my mom crying
and told her, ‘I don’t think I can do it,” she
admits.
The application process held Wall, who
had achieved average MCAT scores, in the
painful balance of suffering by comparison
to higher-performing candidates. “It taught
me how competitive I needed to be and I
realized I wasn’t. I needed to do something
about it.”
Fortunately, Wall’s mother had learned
about the Marshall University Medical
Sciences program from a conference she’d
attended. “They sent me all the information
about the program and it was perfect. It is
for people like me who need to improve
their GPA or MCAT scores and who basically
want a taste of medical school before they
take the giant leap into it.”

Her proficiency and confidence gained
solid ground as she progressed within the
two-year, non-thesis degree in Biomedical
Sciences. She was thrilled to be taking the
same classes as medical students already
accepted into Marshall University School of
Medicine — and excelling in them.
Wall tackled the medical school application
process again. This time, her competence
was at an all-time high.
Having completed the Medical Sciences
program and been accepted into Joan C.
Edwards School of Medicine for Fall 2012,
Wall is finally assured in her choices and her
abilities. “I can go to medical school. I can
sit there and do it well. Medical school is all
about surviving. They are looking for people
who are going to graduate, and the Medical
Sciences program shows them we can do it.”
Alex Muñoz is
breathing a sigh
of relief — but it is
the calm before a
welcome tempest.
He has just passed
the first exam
toward obtaining
his medical license
and is awaiting
news of first-year
rotations.
The self-assured young man considers

continued on page 8
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A Better Advantage, continued from page 7
himself a non-traditional student, having
worked for years as a waiter/bartender after
discovering that a degree and subsequent
position in electrical engineering wasn’t a
good fit. Medicine, he knew, was the right
choice, but he’d have to begin at square
one. His undergraduate degree lacked all
the necessary prerequisites: Chemistry,
Physics, Biology…
Additionally, Muñoz had only spoken
English since the age of 15, the age he
arrived in America with his family from
Columbia, South America.
“I was as far as one can possibly get from
the dream I had,” he admits. Affording one
class at a time at the University of California
at Irvine, Muñoz finished his prerequisites in
only two years. “I wanted to get it done,” he
explains. “I knew it was going to take me a
long time to get into medical school.”
Time ticked onward. Muñoz, always at the
top of his class despite the challenges he
faced with English, performed poorly on his
MCAT, admitting, “I had no business taking
it the first time I took it.”
With medical school unavoidably
postponed, he searched carefully through
listings of master’s degrees and narrowed
his choices to 15, one of which was Marshall
University’s Medical Sciences program.

as far ahead as my
residency.”
Sean Loudin
likes the sound
of his newest
prefixes: Dr. and
Daddy. He and
wife, Ashlee, are
proud parents of
4-year-old Owen
and 2-year-old
Austin. His life’s aspirations, as far as being
husband, father and physician, have come
to fruition. The M.D. from Philippi, W.Va.,
now a member of the Division of NeonatalPerinatal Medicine at Marshall University
and also an Assistant Professor of Pediatrics
at the Joan C. Edwards School of Medicine,
remembers a time when he wasn’t so
self-assured, when it seemed his career
aspirations would be indefinitely tabled.
“I was waitlisted by both medical schools:
West Virginia University and Marshall
University,” he admits.
Resolute, he learned about the graduate
Medical Sciences program at Marshall and
decided to apply. “I thought it would be
the best use of my time while awaiting

reapplication,” explains Loudin.
After completing only one year of
the Medical Sciences program before
reapplication and acceptance into MUSOM,
his role-reversal of now teaching students
attests it was time well spent.
“I’m not sure I would’ve had the motivation
to go through with the MCAT again and
to do what I needed to do to get accepted
had it not been for the Medical Sciences
program.”
Most important to Loudin was familiarity —
being able to sit in medical school classes
with medical students and reviewing the
information on their level. “It took that
added layer of stress away. I got to see
just how medical school would be before
I went. I knew then I was capable of being
successful.”
--The Marshall Medical Sciences program
is for the students determined to make it
in medicine — whether uncertain about
their proficiency, delayed in acceptance
to medical school or making up for lost
academic time. A preview with a purpose,
the classes taken alongside MUSOM
medical students also serve as a testing
ground for preparedness for medicine as a
fulfilling career.

He was immediately impressed with the
level of intelligence of his peers and the
stimulating competition he encountered
within the program. “You get to learn from
medical students and from being around
them, listening to their successes and
failures.” He received his M.S. degree in July
2010, and matriculated into MUSOM the
following semester.

“As an undergraduate student, I was
approached by a faculty member at the
University of Arkansas at Little Rock to do
a research project. He also encouraged me
to get my doctorate in medicinal chemistry.
That eventually led me to Marshall, and I’ve
been here ever since.”

“I’m going to do this no matter what,” he
emphasizes. “Medicine is a marathon, not a
sprint. At one point, I could see as far ahead
as third year medical school. Now, I can see

Sean Loudin, M.D. giving good news to the mother of a soon-to-be released infant
fa l l 2 0 1 2

Discovering Possibilities
Although Dr. Gary Rankin
first plotted to reach the stars
as an honest-to-goodness
astronaut, he hadn’t yet been
exposed to where his true,
lasting contributions would
lie — until he encountered a
research mentor.

Balancing affordability with academic
reputation, Muñoz chose Marshall over
Boston University, both of which granted
acceptance.

MA R S H A L L U N I V E R SI T Y

We Are...Funding Dreams,
by Lisa Shrewsberry

“I never knew Huntington, W.Va. existed,”
he states, adding, “I had seen the movie ‘We
Are Marshall’.”

8

S T O R Y

Graduate training in drug development
followed, and Rankin’s expertise in kidney
toxicology advanced, as did his purpose —
in discovering the impact research can have
on human life.

In addition to being Professor and Chair
of the Department of Pharmacology,
Physiology and Toxicology for Joan C.
Edwards School of Medicine, Rankin is the
principal investigator for and director of
WV-INBRE, part of the IDeA Network of
Biomedical Research Excellence.
WV-INBRE involves 16 colleges and
universities, providing resources,
instrumentation and opportunity beyond
their sponsoring institution’s capacity. For
some students, the projects supported by
WV-INBRE are catalysts to their pursuing
careers in biomedical research.

WV-INBRE: Seeking Solutions
to West Virginia’s Declining
Health Status
“The whole idea was to begin this
competitiveness among institutions in
states like West Virginia,” Rankin explains,

continued on page 10

DR. GARY RANKIN has served as the
principal investigator on one or more NIH
for more than 25 years. In this capacity, he
has been the PI on research grants totaling
approximately $40 million. He is also author
of more than 150 research articles, reviews
and book chapters, mainly in the area of
kidney toxicology.
BIO
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A Better Advantage, continued from page 9
contributions of omega-3 fatty acids as
cancer preventatives and understanding
health effects of coal dust exposure, topics
represented at past symposia bearing
relevance to today’s biggest regional and
national health problems. At the annual
Summer Research Symposium, held
alternately at West Virginia University and
Marshall University, results from mentored
projects serve as building blocks toward
future progress.

“So far, two INBRE grants and
supplements exceed a total
of $32 million. We’re really
funding research in the state
of West Virginia.”
“to stimulate an increase in biomedical
research.” When Marshall University and
WVU submitted separate applications, the
NIH decided to combine the two programs
into one, with Marshall as lead institution.
Rankin still relishes the future possibilities
for WV-INBRE. As conductor to a symphony
of investigators and contributors, partners
and students, Rankin explains how lab
discoveries emerging from W.Va. institutions
translate into added days, weeks, years and
quality of life to its residents and beyond.
“In terms of disease, we are one of the top
states in the country in all the bad statistics.”
The students and researchers working
under his administration are seeking
solutions to the problems behind those
statistics, like cardiovascular disease and
Type II diabetes.
Since its inception in July 2004, WV-INBRE
has funded a number of influential research
projects, such as ACoRN, which stands
for Appalachian Cardiovascular Research
Network and is exploring the genetic basis
of cardiovascular disease.

“In many cases, students help design and
complete their own experiments, which
they present. It is a complete piece of
research. That is the beauty of the program,”
explains Mangiarua.

Dr. Rankin, Director of the WV-INBRE program, asks students to consider the difference they may one day make
to countless lives through biomedical research. Pictured (from left): Diane Anestis, Christopher Racine, Sukanya
Baksi, Dr. Rankin, Jeane Chaffin, and Deborah Preston.
Presently, WV-INBRE supports five major
research projects and eight pilot projects,
representing those making it through the
application and external review process
before selection and subsidy.
The economic scope of WV-INBRE is
something Rankin believes few understand.
“So far, two INBRE grants and supplements
exceed a total of $32,000,000. We’re really
funding research in the state of West
Virginia.”
Researchers empowered toward discovery
through INBRE funds hail from all regions
of the Mountain State. “We are funding
researchers at West Liberty, at Shepherd,

Alderson-Broaddus, Wheeling Jesuit,
Bluefield State… universities and colleges
that are a part of our network either get
direct funding or they get the ability to
have students come (to Marshall or WVU) as
part of the summer research program.”
Recently, Rankin and Dr. Yi Charlie Chen
from Alderson-Broaddus College in Philippi,
W.Va., visited China, testimony to the
far-reaching impact of regional discovery.
Rankin presented data at the World
Cancer Congress in Beijing from a study
he completed with his wife, Dr. Monica
Valentovic. Their research explained how
resveratrol, a component of wine, blocks
the toxicity of certain cancer drugs to the
kidneys.

WV-INBRE Summer Program: Tomorrow’s Logical Dreamers
Dr. Elsa Mangiarua,
Director for both the
Marshall University
and West Virginia
University WVINBRE Summer
Research Programs,
encourages future
researchers and
fortifies tomorrow’s
medical professionals in their careerformative years.
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“Some do have lab experience, but the idea
of bringing them to Marshall University and
WVU (for the summer) is to expose them
to an intensive and structured research
environment. This program is a dedicated
two months of complete immersion in high
level research,” explains Mangiarua.
Students accruing confidence in the
nine-week summer lab demonstrate an
affinity for research as a career. “Many of
our graduates have gone on to develop
themselves at the technical, master’s and

Ph.D. levels,” she states, witnessing many
erstwhile summer interns transitioning into
one of the five research clusters of the MU
Biomedical Sciences Graduate Program.

The lifelong scientist is still amazed how
quickly her students grasp the topics
they are investigating. “They study, they
go to the literature, they learn quickly.
And by the end, you can see these really

DR. ELSA MANGIARUA has served as a grant reviewer for the National
Institutes of Health, National Science Foundation and the Department
of Defense and as an ad-hoc reviewer for the Journal of Cardiovascular
Research, Atherosclerosis and Annals of Clinical & Laboratory Science,
among other publications. Her cardiovascular research has been
extensively funded and published.
young researchers presenting like experts,
answering questions from the audience at
the symposium.”
Taking to the podium at each summer’s
conclusion, her colleague, Dr. Rankin,
further challenges the students to expand
their visionary borders. He asks them to
look around the auditorium and consider
the possibility that one from among them
may some day discover the newest drug to

treat a medicoeconomic and medicosocial
giant such as heart disease.
“Researchers are dreamers,” he reminds, “but
we’re logical dreamers.”
For more information on WV-INBRE, visit
http://www.wv-inbre.net.

Making Much of Time: WV-INBRE 2011 - 2012
Summer Intern Ben Kordusky
Ben Kordusky has made the most of his
WV-INBRE summer experience — twice. He
applied and was accepted into the 2012
program, his second consecutive year. In
2011, he completed research quantifying
the amount of fatty acids in the plasma of
patients with chronic lymphocytic leukemia
who were supplemented with “fish pills” —
the omega 3 fatty acids most common to
consumers. This summer, he was allowed to
take his research a step further to examine
the chemo-sensitizing effects of fatty acids
and how they battle cancer cells, singularly
or in combination with common cancer
treatments.

“At 20, you don’t always know what you
want to be in life. Here, you have the
opportunity to try research and discover
whether or not it’s for you.”

A student from West Virginia Wesleyan
College, considering both dentistry and
biomedical research, Kordusky wanted
more practical experience to help finalize a
decision of continuing on with research as
a career.

Summer interns have explored the
effects of female sex hormones on
the development of brain tumors, the

“I think it’s a wonderful experience, and
anyone who has the opportunity to be a
participant, should,” he says.

West Virginia Wesleyan student and WV-INBRE summer
intern Ben Kordusky just completed his second summer at
Marshall — clarifying the impact of omega 3 fatty acids on
battling cancer cells.
BIOM
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Faculty Update

Summer Research Internship
for Minority Students
“Before the SRIMS program, I was worried that I did not have what it takes to
perform valid research in a lab setting. However, the program did an excellent job
of alleviating my worries by introducing me to a group of students who shared my
aspirations and by providing me with a very knowledgeable mentor with whom I
could work one-on-one.”
– Frankie Woode, Princeton University, Marshall University SRIMS 2012 Intern

Frankie Woode // Princeton University

The Summer Research Internship for Minority Students (SRIMS) program recruited
very successfully this year. Interns for summer 2012 were a delight, and came from
a wide geographical area: Karla Casillas Pagán from Universidad del Este (Puerto
Rico); Diana Elizondo from University of Texas, Brownsville; Kelyn Pittman from
University of Georgia; and Franklin “Frankie” Woode from Princeton University.
Their research contributions were over a period of nine weeks, and in the following
research clusters: Cardiovascular Disease, Obesity, and Diabetes; Infectious and
Immunological Diseases; and Neuroscience and Developmental Biology.

The SRIMS Program was again able to secure funding from the Federation of American Societies for Experimental Biology
Minority Access to Research Careers (FASEB MARC) program to defray some expenses. We hope to receive a sufficient amount
of donations to expand the number of students from four to six in the near future. Your contributions would be appreciated!
http://www.marshall.edu/foundation/givenow.php - SRIMS Program Fund (213073)

R E C E N T G R A D UAT E S

Karla Casillas Pagán // Universidad del Este
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Diana Elizondo // University of Texas, Brownsville

Dr. Carl Gruetter
who researches
within the
Cardiovascular
Disease, Obesity,
and Diabetes
research cluster and
is a faculty member
of the Department

Ph.D. Alumni

“Thanks to Marshall’s Biomedical SRIMS program I further developed my
professional and scientific skills, and have since been accepted to present my
research at different symposia!”
– Karla Casillas Pagán, Universidad del Este, PR

Kelyn Pittman // University of Georgia

Dr. Eric Blough
recently left the
College of Science’s
Department of
Biological Sciences to
join the Department
of Pharmaceutical
Science and Research
in Marshall’s new
School of Pharmacy. He will continue
to mentor current and new Ph.D. and
Research M.S. students, as his research
remains relevant to biomedical
sciences, and he continues a joint
appointment with the School of
Medicine.

Sunil Kakarla,
Ph.D., DVM,
M.S. – Dr. Kakarla
earned his Ph.D.
in Biomedical
Sciences in August
2011 under the
mentorship of Dr.
Eric Blough. His
dissertation title was “Age-Associated
Alterations in the F344XBN Rat heart and
the Efficacy of Chronic Acetaminophen
Ingestion as a Therapeutic Approach.” He
is working as a veterinarian at Banfield
Pet Hospital in Cary, North Carolina.
Juliana Akinsete, Ph.D. – Dr. Akinsete
earned her Ph.D. in Biomedical Sciences
in December 2011 under the mentorship
of Dr. Elaine Hardman. Her dissertation

Dr. Rudy (RuuTong) Wang, an
Associate Professor
in the Department
of Anatomy and
Pathology, retired at
the end of the 20112012 academic year.
Dr. Wang spent 31
years as a faculty member at the Joan C.
Edwards School of Medicine and taught
hundreds of medical students micro
anatomy and neuroanatomy. He was also
the Director of the electron microscope
imaging core when the basic sciences’
departments were located at the Medical
Education Building at the VA Medical
Center. Subsequently, he managed the
electron microscopes when they became
part of the Imaging Center in the Byrd
Biotechnology Center on the campus
of Marshall University. Dr. Wang moved
to Houston, Texas this summer to join
his family, which had relocated to Texas
earlier in the 2011-2012 academic year.
We thank Rudy for his many years of
devoted teaching and wish him and his
family enjoyment and good health in
retirement.

of Pharmacology, Physiology, and
Toxicology is the new chair of the School
of Medicine Curriculum Committee. He
is responsible for the overall design and
delivery of medical education.
Dr. Richard Egleton is
the new Coordinator
for the Neuroscience
and Developmental
Biology Research
Cluster. Dr. Egleton’s
research focuses on
the role of the blood
brain barrier (BBB) and
the neurovascular unit (NVU) in disease
progression.
Dr. Joseph I. Shapiro
joined Marshall
University as the
new Dean of Joan
C. Edwards School
of Medicine. Dean
Shapiro served at the
University of Toledo
College of Medicine in
Toledo, Ohio, and brings with him more
than 30 years of clinical and teaching
experience.

title was “Dietary Interventions Against
Mammary Glands and Prostate Cancers.”
Linda Eastham,
Ph.D. – Dr. Eastham
earned her Ph.D. in
Biomedical Sciences
in May 2012 under
the mentorship of
Dr. Richard Niles.
Her dissertation was
titled “Nuclear Receptor Expression and
Characterization of the Major Retinoic
Acid Target Gene in Melanoma.” Dr.
Eastham is working as a Postdoctoral
Fellow at Progenesis Technologies, LLC in
Huntington, West Virginia.
Siva K. Nalabotu, Ph.D., DVM, M.S.
– Dr. Nalabotu earned his Ph.D. in
Biomedical Sciences in May 2012 under
the mentorship of Dr. Eric Blough. His
dissertation was titled “Evaluation of the
Role of Oxidative Stress, Inflammation
and Apoptosis in the Pulmonary and

the Hepatic Toxicity
Induced by Cerium
Oxide Nanoparticles
Following
Intratracheal
Instillation in Male
Sprague-Dawley Rats.”
He is working as an
associate veterinarian
in the greater Cincinnati, Ohio area.
Anjaiah Katta, Ph.D.,
DVM, M.S. – Dr. Katta
earned his Ph.D. in
Biomedical Sciences
in August 2011 under
the mentorship of
Dr. Eric Blough. His
dissertation title was
“Muscle Plasticity
and Intramuscular
Signaling in the Insulin Resistant Obese
Zucker Rat.” Dr. Katta is working as a
veterinarian at Copper Basin Veterinary
Clinic in Tennessee.
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RESEARCH CLUSTER
Research within Marshall University’s Biomedical Sciences
(BMS) Graduate Program is organized into five research
clusters, derived from the key areas of faculty research
expertise. These research clusters allow the program to take
an interdisciplinary approach and form interdepartmental
collaborations that enhance both faculty research and the
experience of graduate students.

CANCER BIOLOGY CLUSTER

Coordinator – Dr. Beverly Delidow
Facts – 13 faculty members, 9 Ph.D.
students, 5 M.S. students, 8 undergraduate students, 1 high school student, and 2
postdoctoral fellows
Successes – Faculty participated in 6 BMS
courses including Cancer Colloquium,
Foundations of Biomedical Science (BMS
600), Signal Transduction, and Communication Skills for Biomedical Sciences. They also
participated in Molecular Basis of Medicine,
and Medical Physiology and Pharmacology
courses. This cluster holds 9 federal grants
and several other extramural grants. Cluster
graduate students received 5 fellowship
awards. Faculty submitted 7 proposals, published 24 peer-reviewed journal articles and
1 book chapter and presented at numerous
regional and national meetings. Faculty
also edited a published book, reviewed a
number of journal manuscripts and served
as grant reviewers for NIH, NSF, DoD and
private foundation grant programs.
Allison Wolf, a Ph. D. candidate, in Dr.
Claudio’s laboratory, received the Frederick
J. Lotspeich award.

INFECTIOUS AND
IMMUNOLOGICAL DISEASES

Coordinator – Dr. Hongwei Yu
Facts – 6 faculty members, 2 Ph.D. students,
1 post-doctoral fellow
Successes – 12 peer-reviewed studies published, numerous presentations at state and
national meetings. Grant support gained
from the NIH (INBRE program, Dr. Don Primerano) and Cystic Fibrosis Foundation (Dr.
Hongwei Yu). Faculty members reviewed 16
journal transcripts.

Image of Flk-1 expression in the rat choroid
plexus. Flk-1 is a receptor for vascular
endothelial growth factor (VEGF), an
important regulator of vascular function and
development in health and disease.

Successes – 12 extramural research grants
held, 23 articles published in peer-reviewed
journals, numerous presentations given at
either state or national meetings.
Christopher Adams, M.D., second-year
cardiology fellow, won the top poster
presentation prize at regional and national
American College of Cardiology Conferences.
Rebecca Furby, 2011 SRIMS undergraduate
student, won a FASEB-MARC travel award to
the Annual Biomedical Research Conference for Minority Students.
Nalini Santanam, Ph.D., served as an
American Heart Association grant reviewer
(since 2007).

Image of micronucleus in white blood cells

CARDIOVASCULAR,
OBESITY AND DIABETES

Coordinator – Dr. Nalini Santanam
Facts – 15 faculty members, 4 clinical
faculty. In addition, 4 graduate students,
1 postdoctoral fellow, 3 clinical residents/
fellows, 8 undergraduate and 3 medical
students conducted research in members’
laboratories.
14
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Richard Egleton, Ph.D., served as a grant
reviewer for the American Heart Association
and the American Diabetes Association and
for the Israel Science Foundation.
Elsa Mangiarua, Ph.D., reviewed graduate
fellowship applications for both the NSF
and the Department of Defense.
Eric Blough, Ph.D., served as a reviewer for
the US-Israel Bi-National Science Foundation and as an ad hoc reviewer for an NIH
study section on muscle biochemistry.

Image of Pseudomonas aeruginosa, which
turns into a mucoid, slimy form (right)
during chronic lung infections in patients
with Cystic Fibrosis (CF)

TOXICOLOGY AND
ENVIRONMENTAL HEALTH
SCIENCES

Coordinator – Dr. Monica Valentovic
Facts – 7 faculty members, 9 graduate
students
Successes – 16 undergraduates received
research experiences. Faculty members held
8 extramurally funded grants, published 8
journal articles and 4 book chapters, and
led numerous presentations.
Dr. Gary Rankin participated in several
NIH study sections, is a Toxicology editorial
board member and was a finalist for the
PhRMA award in Excellence in Pharmacology/Toxicology.

continued on page 16
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Research Cluster Spotlight, continued from page 15

NEUROSCIENCE AND
DEVELOPMENTAL BIOLOGY

Coordinator – Dr. Richard Egleton
Facts – 10 faculty members, 14 graduate
students
Successes – Faculty laboratories provided
training for 17 undergraduates and 3 medical students. Faculty held 14 extramurally
funded grants, published 8 peer-reviewed
articles and held presentations at numerous
regional and national conferences.

Confocal image of a Drosophila embryo
Dr. Valentovic participated in 2 NIH study
sections, was elected Secretary/Treasurer
of the Division of Toxicology of ASPET, reviewed 20 manuscripts for various journals
and is an assistant editor for Toxicology and
Environmental Health. She collaborated
with Dr. Piyali Dasgupta on a recent NIH
grant to examine capsaicin’s effect on small
cell lung cancer.

Dr. Egleton spoke at a Penn State Symposium on “Prevention of Metabolic Syndrome
by Dietary Phytochemical.”
Dr. Georgel was an invited speaker at 6
venues, including Babaraham Institute in
Cambridge, UK and the Institut de Genetique et de Biologie Moleculaire et Cellulaire,
in Illkrich, France.
Dr. Maria Serrat was featured in “Neuron”
for her MU-ADVANCE Fellowship and for
her research using real-time imaging to
determine the impact of environmental fac-

Image of blood vessels in the plexus
surrounding the tibial growth plate of a live,
anesthetized 5-week old mouse
tors like nutrition, temperature and physical
activity on bone elongation.
Faculty provided extramural grant reviews
for the American Diabetes Association, the
American Heart Association, the BBSRCUK, Pennsylvania Department of Health,
Women in Science Fellowships and the
Department of Army Research Office.

Biomedical Sciences Grant Funding for the 2011-2012 Academic Year
We continue to partner with the University of Kentucky Clinical
and Translational Science Awards (CTSA) and participate
in monthly leadership meetings, retreats and the annual
Appalachian Health Summit. Marshall faculty received several
pilot grant awards and are “grooming” several junior clinical
faculty for submission of applications for the KL2 awards
(mentored research training). At the very end of the academic
year, we received word that the Research Challenge Grant
application to fund the continued development of the West

Virginia Cancer Genomics Network would be awarded for five
years with a cumulative budget of $1.35 million. Marshall with
the Edwards Comprehensive Cancer Center is the lead institution
for the award with subcontracts to partners at the WVU Cancer
Center and Charleston Area Medical Center. The long-term goal
is to expand the network to an Appalachian Cancer Genomics
Network with additional funding from the Appalachian Regional
Commission.

NUMBER OF COMPETITIVE GRANT APPLICATIONS | 63
AMOUNT OF FUNDS REQUESTED | $27,885,944
NUMBER OF COMPETITIVE GRANTS FUNDED | 17
AMOUNT OF FUNDING | $1,114,309
16
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Our program has completed another successful year that has seen
significant changes in the School of Medicine. Changes range from the
newly established scholarship for BMS students by BMS students, to the
hiring of Dr. Joseph Shapiro as our new Dean, to the enhanced M.D./Ph.D.
program.

We are very proud of
our graduate students
for many reasons,
but one stands out in
particular. The BMS
Graduate Student
Organization (GSO)
took the initiative to
raise funds this past
Miranda Carper,
academic year to
Ph.D. Candidate
establish a scholarship
for two BMS research students in the
amount of $500 each. The intent of this
scholarship is to recognize students from
the BMS Graduate
Program who have
demonstrated
outstanding
performance in their
related programs
and to the local and
national community.
This year’s winners are
Steven Rogers,
Miranda Carper (a Ph.D.
Ph.D. Student
candidate researching
in Dr. Pier Paolo Claudio’s laboratory) and
Steven Rogers (a newly accepted Ph.D.
student conducting research in Dr. Eric
Blough’s laboratory).
Additionally, the Biomedical Sciences
Graduate Program recognizes graduate
students each year at the Annual Research
Retreat. For 2011-2012, we congratulate
Allison Wolf (a Ph.D. candidate in Dr. Pier
Paolo Claudio’s lab) for winning the award
for Best Overall Performance as a Graduate
Student; she will receive a plaque and
a paid trip to an international meeting,
up to $3,500. And, for the Best Research
Performance, congratulations go to
Johannes Fahrmann (a Ph.D. candidate in
Dr. Elaine Hardman’s lab); he will receive

a plaque and an expenses paid trip to a
national meeting, up to $2,000.
Another positive development in the BMS
Program is Dean Shapiro’s commitment
to enhancing the M.D./Ph.D. combined
degree. We will recruit candidates for two
M.D./Ph.D. slots in each entering medical
school class, beginning with fall 2013. The
selected students will receive remission
of tuition and receive a Ph.D. level stipend
for all years (approximately seven years)
of the program. There will be safeguards
put in place to insure repayment if the
student drops either part of the dual degree
option. Students also will be required
to submit an M.D./Ph.D. fellowship grant

application before the end of the third
year of the program. It is expected that this
cadre of M.D./Ph.D. students will enhance
the intellectual and translational research
environment in both the medical student
and graduate student training activities.
Our next academic year promises to be as
stimulating with a new pilot grant program,
a new faculty member to be recruited to
replace Dr. Reichenbecher who retired a
few years ago, and interviewing applicants
for the enhanced M.D./Ph.D. track. We
welcome six new Ph.D. candidates, 15
medical sciences students and two research
M.S. students this fall 2012 to help kick off
the new year!

Johannes Fahrmann, Ph.D. Candidate, receives award from Dr. Richard M. Niles
BIOM E D I C A L S C I E N C E S G R A D UAT E P R O G R AM
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Employers of Marshall’s BMS Alumni

BE A PART OF WHAT’S NEW!
New M.D./Ph.D. Program
Program Description – Students in this
track will be involved in course work,
research activities and/or clinical training
for the entire calendar year for the duration
of the program. Also, students will be
required to submit an M.D./Ph.D. fellowship
grant application before the end of their
third year of study. Research clusters
include: Cardiovascular Disease, Obesity,
and Diabetes; Infectious and Immunological
Diseases; Neuroscience and Developmental
Biology; and Toxicology and Environmental

Health Sciences. Students will receive
interdisciplinary research training within
each cluster. Core research services in
Genomics, Imaging, and Flow Cytometry
are also available.
Financial Considerations – Effective with
the 2013 application cycle, there are new
incentives for highly qualified applicants
who are admitted and complete the M.D./
Ph.D. track. These include a waiver of
tuition for the entire length of the program

(typically seven years)
and a yearly stipend
equivalent to the
Ph.D. stipend
(currently $23,000)
for all years of the
program.

New Ph.D. Application Deadlines and Procedure
Deadlines – The BMS Ph.D. Program
has changed its application deadline to
January 15th for domestic applicants and
January 8th for international applicants!
The application and supporting documents
must be received on or before these dates
in order for applicants to be reviewed and
given priority consideration for a stipend
and tuition benefits.
Change in Application Procedure…for
the Ph.D. only – The required application

Newly Designed Website
Marshall’s Biomedical Sciences Graduate
Program recently launched its newly
designed website! You will experience
a friendlier format, and one that puts
a brighter spotlight on Marshall’s BMS
researchers, students, and alumni.

www.marshall.edu/bms
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materials remain the same, but their
destinations have changed. The application
procedure requires submitting certain
items to the Graduate Admissions Office
and others directly to the BMS Graduate
Program Recruitment Coordinator. This
new procedure will help expedite the
application process as well as improve
efficiency. Applications, fees, official GRE
scores, and official transcripts must all go
to the Graduate Admission Office (100
Angus E. Peyton Drive, South Charleston,

WV 25303-1600). Written statements and
official letters of recommendation must be
sent to Diana Maue via e-mail at maue1@
marshall.edu or via mail to: Biomedical
Sciences Graduate Program, Marshall
University, One John Marshall Drive, BBSC
301-F, Huntington, WV 25755-2195. Be sure
to check the website for specifics!

Applied Biosystems
Brown University, Division of Biology and Medicine
East Ohio Regional Hospital
Federal Bureau of Investigation, Weapons of Mass Destruction
Kent State University, Exercise Science Physiology
L’Oréal
Long Island Jewish Medical Center
Marshall University, Forensic Science Graduate Program
Morehead State University
Mountwest Community & Technical College
National Institutes of Health
Progenesis Technologies, LLC
Rite Aid Pharmacy
Shawnee State University, Department of Natural Sciences
Syntonix Pharmaceuticals, a subsidiary of Biogen Idec
University of Alabama, Birmingham
University of Charleston School of Pharmacy
University of Hawaii at Manoa
University of Kentucky Graduate Center for Toxicology
University of Massachusetts, Worcester
University of North Carolina, Wilmington
University of Virginia
University of Maryland Medical Career Center, Department of Oncology
Wheeling Jesuit University
Wil Research Laboratories
Zymed Laboratories

“Marshall’s BMS Ph.D.
Program strengthened my
analytical and problem
solving skills, giving me the
strategic mindset critical to
responding effectively to
threats of bioterrorism.”
– Nathan Head, Ph.D., Supervisory
Agent FBI Weapons of Mass Destruction
Directorate and alumnus of the BMS Ph.D.
Program

Incoming Biomedical Sciences Ph.D.
Students for Fall 2012
Caroline Hunter, B.S.
Roanoke College (VA) – B.S.
Lina Niu, B.E., M.S.
Xiangtan University (China) – B.E.; Marshall University –
M.S. in Biological Sciences
Sean Piwarski, B.S., B.A., M.S.
California Lutheran University – B.S., B.A.; Marshall
University – M.S. in Forensic Science
Steven Rogers, B.S.
Marshall University – B.S.
Holly Tamski, B.S.
Seton Hill University (PA) – B.S.
Justin Tomblin, B.S.
Marshall University – B.S.

Incoming Biomedical Sciences Research M.S.
Students for Fall 2012:
Adam Fischer
Glenville State University (WV) – B.S.
William O’Toole
Marshall University – B.S.

Incoming Biomedical Sciences M.S., Medical
Sciences Students for Fall 2012:
Mujiba Ansari – University of South Florida
Oksana Bailiff – Marshall University
Allison Dillard – West Virginia University
Morgan Efaw – Marshall University
Brad Gillon – College of The Holy Cross (MA)
Larry Harbrecht – Marshall University
Jarrod Harman – Marshall University
John Hurley – Marshall University
Chirag Patel – Marshall University
Travis Potter – University of Tennessee, Knoxville
Leslee Rice – Marshall University
Bill Rollyson – West Virginia State University
Adam Rudmann – The Ohio State University
Cathryn Stevenson – Grambling State University (LA)
Michelle Studeny – University of Kentucky
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Make a Gift to the Biomedical Sciences Graduate Program
The BMS Graduate Program continues to thrive, but is always seeking ways to make improvements for
its students. Your financial contribution will support BMS Ph.D. students via scholarships/stipends or
fund students’ travel to biomedical meetings. Financial support can also be given to strengthen and
expand the Biomedical Sciences Summer Research Internship for Minority Students (SRIMS).
Contribution of any amount is both helpful and appreciated!
Please contribute to the BMS Graduate Program Fund (213078) or the SRIMS Program Fund (213073)
online at http://www.marshall.edu/foundation/givenow.php, or by mailing a check payable to:
The Marshall University Foundation, Inc.
519 John Marshall Drive
Huntington, West Virginia 25705
THANK YOU!
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